Cargando…
Ex Vivo Infection of Live Tissue with Oncolytic Viruses
Oncolytic Viruses (OVs) are novel therapeutics that selectively replicate in and kill tumor cells(1). Several clinical trials evaluating the effectiveness of a variety of oncolytic platforms including HSV, Reovirus, and Vaccinia OVs as treatment for cancer are currently underway(2-5). One key charac...
Autores principales: | Diallo, Jean-Simon, Roy, Dominic, Abdelbary, Hesham, De Silva, Naomi, Bell, John C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MyJove Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3197059/ https://www.ncbi.nlm.nih.gov/pubmed/21730946 http://dx.doi.org/10.3791/2854 |
Ejemplares similares
-
Exploiting tumor epigenetics to improve oncolytic virotherapy
por: Forbes, Nicole E., et al.
Publicado: (2013) -
Cell carriers for oncolytic viruses: current challenges and future directions
por: Roy, Dominic G, et al.
Publicado: (2013) -
Combination of Paclitaxel and MG1 oncolytic virus as a successful strategy for breast cancer treatment
por: Bourgeois-Daigneault, Marie-Claude, et al.
Publicado: (2016) -
The ex vivo purge of cancer cells using oncolytic viruses: recent advances and clinical implications
por: Tsang, Jovian J, et al.
Publicado: (2015) -
Differential Susceptibility of Ex Vivo Primary Glioblastoma Tumors to Oncolytic Effect of Modified Zika Virus
por: Garcia, Gustavo, et al.
Publicado: (2023)